154 related articles for article (PubMed ID: 32200677)
1. Cardioprotective Effects of the Novel Compound Vastiras in a Preclinical Model of End-Organ Damage.
Altara R; da Silva GJJ; Frisk M; Spelta F; Zouein FA; Louch WE; Booz GW; Cataliotti A
Hypertension; 2020 May; 75(5):1195-1204. PubMed ID: 32200677
[TBL] [Abstract][Full Text] [Related]
2. Effects of calcium sensitizer OR-1986 on a cardiovascular mortality and myocardial remodelling in hypertensive Dahl/Rapp rats.
Louhelainen M; Merasto S; Finckenberg P; Vahtola E; Kaheinen P; Leskinen H; Levijoki J; Pollesello P; Haikala H; Mervaala EM
J Physiol Pharmacol; 2009 Sep; 60(3):41-7. PubMed ID: 19826180
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
Biala A; Finckenberg P; Korpi A; Loytainen M; Martonen E; Levijoki J; Mervaala E
J Physiol Pharmacol; 2011 Jun; 62(3):275-85. PubMed ID: 21893687
[TBL] [Abstract][Full Text] [Related]
4. Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone rats.
Barone FC; Coatney RW; Chandra S; Sarkar SK; Nelson AH; Contino LC; Brooks DP; Campbell WG; Ohlstein EH; Willette RN
Cardiovasc Res; 2001 Jun; 50(3):525-37. PubMed ID: 11376628
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats.
Yu M; Moreno C; Hoagland KM; Dahly A; Ditter K; Mistry M; Roman RJ
J Hypertens; 2003 Jun; 21(6):1125-35. PubMed ID: 12777949
[TBL] [Abstract][Full Text] [Related]
6. Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats.
Louhelainen M; Vahtola E; Kaheinen P; Leskinen H; Merasto S; Kytö V; Finckenberg P; Colucci WS; Levijoki J; Pollesello P; Haikala H; Mervaala EM
Br J Pharmacol; 2007 Apr; 150(7):851-61. PubMed ID: 17325658
[TBL] [Abstract][Full Text] [Related]
7. Rat chromosome 19 transfer from SHR ameliorates hypertension, salt-sensitivity, cardiovascular and renal organ damage in salt-sensitive Dahl rats.
Wendt N; Schulz A; Siegel AK; Weiss J; Wehland M; Sietmann A; Kossmehl P; Grimm D; Stoll M; Kreutz R
J Hypertens; 2007 Jan; 25(1):95-102. PubMed ID: 17143179
[TBL] [Abstract][Full Text] [Related]
8. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
[TBL] [Abstract][Full Text] [Related]
9. Ghrelin counteracts salt-induced hypertension via promoting diuresis and renal nitric oxide production in Dahl rats.
Aoki H; Nakata M; Dezaki K; Lu M; Gantulga D; Yamamoto K; Shimada K; Kario K; Yada T
Endocr J; 2013; 60(5):571-81. PubMed ID: 23328675
[TBL] [Abstract][Full Text] [Related]
10. Chronic angiotensin II antagonism with losartan in one-kidney, one clip hypertensive rats: effect on cardiac hypertrophy, urinary sodium and water excretion and the natriuretic system.
Garcia R; Bonhomme MC; Diebold S
J Hypertens; 1996 Jan; 14(1):81-9. PubMed ID: 12013499
[TBL] [Abstract][Full Text] [Related]
11. TVP1022 attenuates cardiac remodeling and kidney dysfunction in experimental volume overload-induced congestive heart failure.
Abassi ZA; Barac YD; Kostin S; Roguin A; Ovcharenko E; Awad H; Blank A; Bar-Am O; Amit T; Schaper J; Youdim M; Binah O
Circ Heart Fail; 2011 Jul; 4(4):463-73. PubMed ID: 21558446
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic peptide gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in salt-sensitive rats.
Lin KF; Chao J; Chao L
Hum Gene Ther; 1998 Jul; 9(10):1429-38. PubMed ID: 9681414
[TBL] [Abstract][Full Text] [Related]
13. CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats.
Arai K; Tsuruoka H; Homma T
Eur J Pharmacol; 2015 Dec; 769():266-73. PubMed ID: 26607463
[TBL] [Abstract][Full Text] [Related]
14. Sustained Activation of Guanylate Cyclase-A with TDT, a Natriuretic Peptide Derivative, Exhibits Cardiorenal Protection in Dahl Salt-Sensitive Hypertensive Rats.
Oishi S; Suzuki N; Hasui Y; Homma T; Obana M; Nagayama T; Fujio Y
J Pharmacol Exp Ther; 2017 Dec; 363(3):402-410. PubMed ID: 29021382
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory Effects of Tofogliflozin on Cardiac Hypertrophy in Dahl Salt-Sensitive and Salt-Resistant Rats Fed a High-Fat Diet.
Kimura T; Nakamura K; Miyoshi T; Yoshida M; Akazawa K; Saito Y; Akagi S; Ohno Y; Kondo M; Miura D; Wada J; Ito H
Int Heart J; 2019 May; 60(3):728-735. PubMed ID: 31105148
[TBL] [Abstract][Full Text] [Related]
16. Human adrenomedullin gene delivery protects against cardiac hypertrophy, fibrosis, and renal damage in hypertensive dahl salt-sensitive rats.
Zhang JJ; Yoshida H; Chao L; Chao J
Hum Gene Ther; 2000 Sep; 11(13):1817-27. PubMed ID: 10986555
[TBL] [Abstract][Full Text] [Related]
17. L-arginine administration normalizes pressure natriuresis in hypertensive Dahl rats.
Patel A; Layne S; Watts D; Kirchner KA
Hypertension; 1993 Dec; 22(6):863-9. PubMed ID: 8244518
[TBL] [Abstract][Full Text] [Related]
18. Blunted renal responses to atrial natriuretic peptide and its reversal by unclipping in one-kidney, one clip Goldblatt hypertensive rats.
Huang WC; Wu JN
J Hypertens; 1997 Feb; 15(2):181-9. PubMed ID: 9469794
[TBL] [Abstract][Full Text] [Related]
19. Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension.
Eiskjaer H; Nielsen CB; Pedersen EB
J Intern Med; 1994 Dec; 236(6):665-74. PubMed ID: 7989902
[TBL] [Abstract][Full Text] [Related]
20. Effects of fixed-dose isosorbide dinitrate/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure.
Wilson RM; De Silva DS; Sato K; Izumiya Y; Sam F
Hypertension; 2009 Sep; 54(3):583-90. PubMed ID: 19620510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
